Clinical Diagnostics

Research Kits
Are you a provider of research kits looking to expand the range of your
product offerings? The AD drug development market represents a large
unmet need:  currently announced phase 2 and 3 clinical trials will enroll
some 150,000 patients (to 2010). Our assays are validated in high-
throughput flow cytomtetry and ELISA formats. We seek licensees
who will produce and market kits for the performance of our assays
in clinical trial development programs and research. 

> IN VITRO DIAGNOSTICS